Molecure is an innovative biopharmaceutical company that specializes in discovery, development, and commercialization of novel therapeutics.
Molecure has raised $12.6M in total funding. The most recent round was Post-IPO Secondary. The last funding was announced in July 2023.
Molecure is headquartered in Warsaw, Poland.
Molecure is an innovative biopharmaceutical company that specializes in discovery, development, and commercialization of novel therapeutics.
Molecure is at the Post-IPO Secondary stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Molecure — Funding & Investors." VCBacked, July 18, 2023, https://www.vcbacked.co/company/molecure. Accessed August 14, 2026.
VCBacked. (2023). Molecure — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/molecure
{{cite web |title=Molecure — Funding & Investors |url=https://www.vcbacked.co/company/molecure |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated